ISSN: 1093-2607

Journal Home

Journal Guideline

Human Antibodies Q3 Unclaimed

IOS Press BV Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Human Antibodies is a journal indexed in SJR in Medicine (miscellaneous) and Immunology with an H index of 28. It has an SJR impact factor of 0,365 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,365.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Immunology and Allergy (Q3) Immunology and Allergy (Q3) Medicine (miscellaneous) (Q3) Immunology (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,365

SJR Impact factor

28

H Index

8

Total Docs (Last Year)

84

Total Docs (3 years)

256

Total Refs

129

Total Cites (3 years)

84

Citable Docs (3 years)

1.79

Cites/Doc (2 years)

32.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Swiss Medical Weekly Q3
Neurologia Q3
Canadian Journal of Experimental Psychology Q3
Journal of Physiology and Pharmacology Q3
Revista do Instituto de Medicina Tropical de Sao Paulo Q3

Compare this journals

Aims and Scope

Best articles by citations

Efficient in vitro affinity maturation of phage antibodies using BIAcore guided selections

Circulating innate and adaptive immunity against anti-Haemophilus influenzae type b

Isolation of human monoclonal antibodies binding to B fragment of diphtheria toxin

Effect of hypocomplementemia on perinatal outcomes of pregnancies with autoimmune disorders

Assessment of anti-cancer effects of koenimbine on colon cancer cells

In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody

Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments

Generation of monoclonal antibody CIBCgp185 against C-erbB-2 oncoprotein and its clinical evaluation

Generation of mouse-human hybridomas secreting human monoclonal antibodies to Japanese cedar pollen allergen Cry j1

Perceptions of leadership, motivation, structure, and assurance for implementation of emergency medical services in Ethiopia: Perspectives of emergency medical services case teams based on focus group discussions

Nanobodies: The "Magic Bullets" in therapeutics, drug delivery and diagnostics

Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals

SHOW MORE ARTICLES

Impact of food insecurity and malnutrition on the burden of Non-communicable diseases and death in Ethiopia: A situational analysis

The relationship between health literacy and quality of life among hemodialysis patients: An integrative review

Construction and development of FimH lectin domain for rising immune response after injection by uropathogenic E. coli

Pilot study of anti-lipopolysaccharide human monoclonal antibody MAB-T88 in patients with gram-negative sepsis

Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes

Phage antibodies from combinatorial library neutralize vaccinia virus

Potential of primate monoclonal antibodies to substitute for human antibodies: nucleotide sequence of chimpanzee Fab fragments

Immunofluorescent localization of C-erbB-2 oncoprotein in breast cancer: A preliminary study

Antibody polyspecificity and neutralization of HIV-1: A hypothesis

Fine-tuning ofroutine combined first- trimester screening: The ratio of serum-free- beta-human chorionic gonadotropin (fbeta-hCG) to pregnancy-associated plasma protein-A (PAPP-A) could improve performance of Down syndrome screening program, a retros

Prevalence of tetanus immunity in the Egyptian population

Production of anti-tumor human monoclonal antibodies using different approaches